Methylphenidate-induced motor activity in rats: Modulation by melatonin and vasopressin

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 1, 2003, Pages 67-73

  Appenrodt, Edgar ^a   Schwarzberg, Helmut ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Behaviour; Melatonin; Methylphenidate; Motor activity; Pineal gland; Rat; Ritalin; Vasopressin

Indexed keywords

MELATONIN; METHYLPHENIDATE; NEUROPEPTIDE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; MOTOR ACTIVITY; NEUROMODULATION; NONHUMAN; PINEAL BODY; PINEALECTOMY; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0038635954     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00037-6     Document Type: Article

References (45)

1. Albers H.E., Karom M., Smith D. Serotonin and vasopressin interact in the hypothalamus to control communicative behavior. NeuroReport. 13:2002;931-933.
2. Alexiuk N.A.M., Vriend J.P. Extrahypothalamic effects of melatonin administration on serotonin and norepinephrine synthesis in female Syrian hamsters. J. Neural Transm. Gen. Sect. 94:1993;43-53.
3. Alexiuk N.A.M., Vriend J.P. Melatonin reduces dopamine content in the neurointermediate lobe of the male Syrian hamsters. Brain Res. Bull. 32:1993;433-436.
4. Appenrodt E., Schwarzberg H. Septal vasopressin modulates motility and passive avoidance in pinealectomised rats. Physiol. Behav. 66:1999;757-761.
5. Appenrodt E., Schwarzberg H. Central vasopressin administration failed to influence anxiety behaviour after pinealectomy in rats. Physiol. Behav. 68:2000;735-739.
6. Appenrodt E., Bojanowska E., Janus J., Stempniak B., Guzek J.W., Schwarzberg H. Effect of methylphenidate on oxytocin and vasopressin levels in pinealectomised rats during the light-dark cycle. Pharmacol. Biochem. Behav. 58:1997;415-419.
7. Appenrodt E., Juszczak M., Schwarzberg H. Septal vasopressin induced preservation of social recognition in rats was abolished by pinealectomy. Behav. Brain Res. 134:2002;67-73.
8. Bhattacharya S.K., Bhattacharya A., Chakrabarti A. Anxiogenic activity of intraventricularly administered arginine vasopressin in the rat. Biog. Amines. 14:1998;367-385.
9. Bojanowska E., Juszczak M., Guzek J.W., Dabrowski R. The pineal and vasopressin synthesis. Neuro Endocrinol. Lett. 19:1998;202-206.
10. Bojanowska E., Juszczak M., Guzek J.W., Dabrowski R. The pineal and oxytocin synthesis. J. Physiol. Pharmacol. 50:1999;121-128.
11. Butcher S.P., Liptrot J., Aburthnott G.W. Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122:1991;245-248.
12. Crawford C.A., McDougall S.A., Meier T.L., Collins R.L., Watson J.B. Repeated methylphenidate treatment induces behavioural sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology. 136:1998;34-43.
13. Dluzen D.E., Muraoka S., Landgraf R. Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats. Neurosci. Lett. 254:1998;161-164.
14. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., Landgraf R. Behavioural consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci. Biobehav. Rev. 20:1996;341-358.
15. Forsling M.L. Diurnal rhythms in neurohypophysial function. Exp. Physiol. 85S:2000;179s-186s.
16. Forsling M.L., Stoughton R.P., Zhou Y., Kelestimur H., Demaine C. The role of the pineal in the control of the daily patterns of neurohypophysial hormone secretion. J. Pineal Res. 14:1993;45-51.
17. Fray P.J., Sahakian B.J., Robbins T.W., Koob G.F., Iversen S.D. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of D-amphetamine and apomorphine. Psychopharmacology (Berl.). 69:1980;253-259.
18. Gatley S.J., Pan D., Chen R., Chaturvedi G., Ding Y.S. Affinities of methylphenidate derivates for dopamine, norepinephrine and serotonin transporters. Life Sci. 58:1996;PL231-PL239.
19. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res. 727:1996;13-21.
20. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behaviour in the rat. Brain Res. 777:1997;1-12.
21. Gaytan O., Al-Rahim S., Swann A., Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 61:1997;PL101-PL107.
22. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res. 864:2000;24-39.
23. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Getley S.J., Marsteller D.et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J. Pharmacol. Exp. Ther. 295:2000;51-57.
24. Golombek D.A., Pévet P., Cardinali D.P. Melatonin effects on behaviour: possible mediation by the central GABAergic system. Neurosci. Biobehav. Rev. 20:1996;403-412.
25. Günther O., Kovács G.L., Szabó G., Schwarzberg H., Telegdy G. Differential effect of vasopressin on open-field activity and passive avoidance behaviour following intracerebroventricular versus intracisternal administration in rats. Acta Physiol. Hung. 71:1988;203-206.
26. Honma S., Honma K. Locomotor rhythms induced by methylphenidate in suprachiasmatic nuclei-lesioned rats. Neurosci. Lett. 137:1992;24-28.
27. Hurd Y.L., Ungerstedt U. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166:1989;251-260.
28. 2 receptor in the suprachiasmatic nucleus-slice culture of rats. Brain Res. 889:2000;214-219.
29. Juszczak M., Drobnik J., Guzek J.W., Schwarzberg H. Effects of pinealectomy and melatonin on vasopressin-potentiated passive avoidance in rats. J. Physiol. Pharmacol. 47:1996;621-627.
30. Juszczak M., Appenrodt E., Guzek J.W., Schwarzberg H. Effects of oxytocin and vasopressin on retrieval of passive avoidance response in melatonin-treated and/or pinealectomised male rats. Neuro Endocrinol. Lett. 20:1999;77-81.
31. Khaldy H., Leon J., Escames G., Bikjdaouene L., Garcia J.J., Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and melatonin treatment. Neuroendocrinology. 75:2002;201-208.
32. Kovács G.L., Bohus B., Versteeg D.H.G., De Kloet E.R., De Wied D. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Res. 175:1979;303-314.
33. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68:1997;2032-2037.
34. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296:2001;876-883.
35. McDougall S.A., Collins R.L., Karper P.E., Watson J.B., Crawford C.A. Effects of methylphenidate treatment in young rat: sensitization of both locomotor activity and stereotyped sniffing. Exp. Clin. Psychopharmacol. 7:1999;208-218.
36. Miguez J.M., Martin F.J., Lema M., Aldegunde M. Changes in serotonin level and turnover in discrete hypothalamic nuclei after pinealectomy and melatonin administration to rats. Neurochem. Int. 29:1996;651-658.
37. Miguez J.M., Martin F.J., Aldegunde M. Melatonin effects on serotonin synthesis and metabolism in the striatum, nucleus accumbens, and dorsal and median raphe nuclei of rats. Neurochem. Res. 22:1997;87-92.
38. Palaoglu S., Palaoglu O., Akarsu E.S., Ayhan I.H., Ozgen T., Erbengi A. Behavioural assessment of pinealectomy and foetal pineal gland transplantation in rats: Part II. Acta Neurochir. (Wien). 128:1994;8-12.
39. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:1991;151-180.
40. Roffman J.L., Raskin L.A. Stereotyped behavior: effects of d-amphetamine and methylphenidate in the young rat. Pharmacol. Biochem. Behav. 58:1997;1095-1102.
41. 2 receptor agonist. Psychopharmacology. 152:2000;275-282.
42. Swerdlow N.R., Koob G.F., Cador M., Lorang M., Hauger R.L. Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol. Biochem. Behav. 45:1993;629-637.
43. Tyagi M.G., Handa R.K., Stephen P.M., Bapna J.S. Vasopressin induces dopamine release and cyclic AMP efflux from the brain of water deprived rats: inhibitory effect of vasopressin V2 receptor-mediated phosphorylation. Biol. Signals Recept. 7:1998;328-336.
44. Vacher C.M., Fretier P., Creminon C., Calas A., Hardin-Pouzet H. Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J. Neurosci. 22:2002;1513-1522.
45. Yamashita T., Liu X., Onaka T., Honda K., Saito T., Yagi K. Vasopressin differentially modulates noradrenaline release in the rat supraoptic nucleus. NeuroReport. 12:2001;3509-3511.